During Q4 2018 the big money sentiment increased to 0.95. That’s change of 0.07, from 2018Q3’s 0.88. 32 investors sold all, 65 reduced holdings as Allscripts Healthcare Solutions, Inc. ratio is positive. 62 increased holdings while 30 funds bought holdings. Funds hold 170.44 million shares thus 0.27% less from 2018Q3’s 170.90 million shares.

United Svcs Automobile Association reported 1.28M shs stake. Macquarie Ltd reported 110,482 shs stake. Susquehanna Intl Llp invested 0% of its capital in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Neuberger Berman Grp Inc Ltd Company stated it has 2.88 million shs. First Advsr L P, Illinois-based fund reported 37,536 shs. North Star Investment Mngmt Corporation reported 6 shs. California-based Wells Fargo And Mn has invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). S&T Bancorporation Pa accumulated 447,568 shs or 1% of the stock. Fisher Asset Mgmt Ltd holds 5.01 million shs or 0.07% of its capital. Northern Tru holds 0.01% or 2.65M shs in its capital. Engineers Gate Manager Ltd Partnership holds 72,627 shs. Bessemer Grp holds 1,000 shs. The Connecticut-based Quantitative Systematic Strategies Llc has invested 0.04% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Texas Permanent School Fund holds 0.02% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) or 114,331 shs. Bank & Trust Of America Corporation De invested in 1.69M shs.

Allscripts Healthcare Solutions, Inc. registered $170,721 net activity with 5 buys and 2 sales since September 14, 2018. JUDGE JONATHAN had bought 9,622 shs worth $99,841 on Friday, December 14. $10,006 worth of stock was bought by Aspinall Mara G. on Friday, December 14. On Thursday, December 13 the insider Poulton Richard J. sold $589,233. 1,000 shs were bought by Garrison Greg, worth $9,798. The insider Black Paul bought $250,027. Farley Brian also sold $72,000 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) shs.

Reiterated Allscripts (NASDAQ:MDRX) Rating.

New York: On Tuesday, 12 March, a research report was published of Allscripts (NASDAQ:MDRX). Its “Buy” Rating restate at Canaccord Genuity. Stock research analysts have target of $13 which gives 23.11 % upside potential on firm’s stock.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage

In total 8 analysts cover Allscripts Healthcare (NASDAQ:MDRX). “Buy” rating has 3, “Sell” are 1, while 4 are “Hold”. 38% are bullish. 14 are the (NASDAQ:MDRX)’s analyst reports since November 2, 2018 according to StockzIntelligence Inc. In Friday, November 2 report Robert W. Baird maintained the stock with “Outperform” rating. On Friday, November 2 the stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Neutral” rating by Cantor Fitzgerald. The stock rating was maintained by Morgan Stanley with “Sell” on Monday, February 25. In Friday, November 2 report JP Morgan downgraded the stock to “Neutral” rating. On Friday, February 22 the stock has “Buy” rating by Cowen & Co. On Thursday, February 21 the company was maintained by Cantor Fitzgerald. On Friday, November 2 the stock has “Buy” rating by Bank of America. On Friday, January 18 the firm has “Overweight” rating by KeyBanc Capital Markets given. On Friday, November 2 the company was maintained by Citigroup. On Wednesday, November 14 the stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Hold” rating by Argus Research.

Ticker’s shares touched $10.56 during the last trading session after 1.64% change.Currently Allscripts Healthcare Solutions, Inc. is downtrending after 22.79% change in last March 13, 2018. MDRX has 2.26 million shares volume. MDRX underperformed the S&P 500 by 27.16%.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s earnings release is anticipated by WallStreet on May, 2, RTT reports. The EPS diference is $0.00 or 0.00 % from last years number. Previous year: $0.11; Analysts forcast: $0.11. MDRX’s profit could reach $18.84 million if the current EPS of $0.11 is accurate. Wall Street now forecasts -31.25 % negative EPS growth despite Allscripts Healthcare Solutions, Inc. last quarter’s EPS of $0.16.

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.The company has $1.81 billion market cap. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.5.11 is the P/E ratio. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

For more Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news published recently go to: Globenewswire.com, Streetinsider.com, Globenewswire.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “Allscripts closes previously announced sale of its interests in Netsmart – GlobeNewswire” published on January 02, 2019, “Pre-Open Stock Movers 02/22: (W) (XOG) (VYGR) Higher (STMP) (KHC) (DBX) Lower (more…) – StreetInsider.com” on February 22, 2019, “Allscripts announces fourth quarter and 2018 full-year results – GlobeNewswire” with a publish date: February 21, 2019, “Allscripts (MDRX) Misses Q3 Earnings and Revenue Estimates – Nasdaq” and the last “Saint Anthony Hospital expands Allscripts partnership to enable clinical data integration between ambulatory and acute settings – Nasdaq” with publication date: March 04, 2019.